News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Terry Hisey

Advertisement

Articles by Terry Hisey

Pharma’s Big Push for Value

ByTerry Hisey,Brett J. Davis
May 5th 2016

An “how to” primer for life sciences companies on applying end-to-end evidence strategies in demonstrating product value.

Advertisement

Latest Updated Articles

  • Pharma’s Big Push for Value
    Pharma’s Big Push for Value

    Published: May 5th 2016 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Novavax Enters $530 Million License Agreement with Pfizer for Vaccine Development

2

JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry

3

WHO Finalizes United States’ Withdrawal from Organization: Report

4

Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk

5

TopGum Signs $12 Million Letter of Intent to Acquire U.S. Pharmaceutical Manufacturing Operations

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us